☆ 4.5 Letter

Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis

BONE MARROW TRANSPLANTATION (2023)

Related references

Note: Only part of the references are listed.

Letter Hematology

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

Muna Qayed et al.

BLOOD ADVANCES (2022)

Add to Collection

Article Oncology

Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD

Benjamin Watkins et al.

Summary: The study showed that adding abatacept to URD HCT was safe and effective in reducing AGVHD and improving SGFS. These results suggest that abatacept may have a significant positive impact on transplant outcomes related to AGVHD, particularly in HLA-mismatched HCT.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Hematology

Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis

Muna Qayed et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)

Add to Collection

Review Medicine, Research & Experimental

Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician

Lawrence Blonde et al.

ADVANCES IN THERAPY (2018)

Add to Collection

Editorial Material Medicine, General & Internal

Real-World Evidence - What Is It and What Can It Tell Us?

Rachel E. Sherman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Medicine, General & Internal

HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry

Loren Gragert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Hematology

HLA-C Antigen Mismatch Is Associated with Worse Outcome in Unrelated Donor Peripheral Blood Stem Cell Transplantation

Ann Woolfrey et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)

Add to Collection

Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis

Related references

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD

Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis

Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician

Real-World Evidence - What Is It and What Can It Tell Us?

HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry

HLA-C Antigen Mismatch Is Associated with Worse Outcome in Unrelated Donor Peripheral Blood Stem Cell Transplantation

Export Citation

Share Paper